Daniel J Donoghue Selected Research

Daniel J Donoghue Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 07/2004
6	Genetic Translocation (Chromosomal Translocation) 12/2022 - 01/2017
6	Multiple Myeloma 01/2018 - 07/2004
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 07/2004
5	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2016
4	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2013
3	Lymphoma (Lymphomas) 01/2020 - 07/2005
3	Achondroplasia 01/2014 - 07/2004
3	Carcinoma (Carcinomatosis) 01/2013 - 07/2004
2	Mouth Neoplasms (Oral Cancer) 11/2023 - 01/2016
2	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2016
2	Gallbladder Neoplasms (Gallbladder Cancer) 11/2023 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 11/2023 - 01/2016
2	Leukemia 01/2020 - 07/2005
2	Adenocarcinoma 11/2016 - 01/2013
2	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 09/2008 - 07/2004
1	Papillary Thyroid Cancer 12/2022
1	Sarcoma (Soft Tissue Sarcoma) 12/2022
1	Glioma (Gliomas) 12/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Type I Thanatophoric Dysplasia 01/2021
1	Cholangiocarcinoma 12/2020
1	Hematologic Neoplasms (Hematological Malignancy) 04/2019
1	Adenocarcinoma of Lung 09/2018
1	Nasopharyngeal Carcinoma 09/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Carcinogenesis 08/2015
1	Inflammation (Inflammations) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Tuberous Sclerosis (Bourneville's Disease) 09/2011

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2008
7	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 08/2015
5	Phosphotransferases (Kinase)IBA 12/2022 - 01/2014
4	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2014 - 07/2004
3	AndrogensIBA 01/2021 - 01/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 07/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 01/2014
2	tyrosine receptor (receptor, tyrosine)IBA 12/2022 - 08/2015
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 01/2013
2	Tyrosine (L-Tyrosine)FDA Link 01/2014 - 07/2005
1	Tyrosine Kinase InhibitorsIBA 12/2022
1	entrectinibIBA 12/2022
1	repotrectinibIBA 12/2022
1	selitrectinibIBA 12/2022
1	larotrectinibIBA 12/2022
1	SolventsIBA 12/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	IntegrinsIBA 01/2022
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2022
1	LigandsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VimentinIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	DisulfidesIBA 01/2021
1	SuspensionsIBA 03/2020
1	ChaperoninsIBA 01/2020
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2020
1	SaltsIBA 01/2020
1	ras ProteinsIBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	trkC ReceptorIBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2016
1	AntigensIBA 11/2016
1	Immune Sera (Antisera)IBA 11/2016
1	Codon (Codons)IBA 01/2014
1	PhosphopeptidesIBA 01/2013
1	titanium dioxide (Titania)FDA Link 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Tuberous Sclerosis Complex 2 ProteinIBA 09/2011
1	Cyclin B1IBA 09/2011
1	Masoprocol (Actinex)FDA Link 09/2008
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2005
1	Phospholipases (Phospholipase)IBA 07/2005
1	Focal Adhesion Kinase 2IBA 07/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2013
2	Prostatectomy (Retropubic Prostatectomy) 03/2020 - 01/2013
2	Castration 03/2020 - 01/2013
1	Drug Therapy (Chemotherapy) 03/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2013